Novel tripeptide RKH derived from <i>Akkermansia muciniphila</i> protects against lethal sepsis

Abstract

We revealed that a novel tripeptide, RKH, derived from live AKK, may act as a novel endogenous antagonist for TLR4. RKH may serve as a novel potential therapeutic approach to combat lethal sepsis after successfully translating its efficacy into clinical practice.